Similar articles

• Outpatient management of febrile neutropenia: time to revise the present treatment strategy.

  Carstensen M, Sørensen JB. Carstensen M, et al. J Support Oncol. 2008 May-Jun;6(5):199-208. J Support Oncol. 2008. PMID: 18551855 Review.
• Outpatient management of febrile neutropenia: concerns for the future.

  Cox HL, Donowitz GR. Cox HL, et al. J Support Oncol. 2008 May-Jun;6(5):217-8. J Support Oncol. 2008. PMID: 18551856 No abstract available.
• Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.

  Teuffel O, Amir E, Alibhai SM, Beyene J, Sung L. Teuffel O, et al. Pediatrics. 2011 Feb;127(2):e279-86. doi: 10.1542/peds.2010-0734. Epub 2011 Jan 10. Pediatrics. 2011. PMID: 21220399
• Outpatient oral antibiotics for febrile neutropenic cancer patients.

  Ouvrier MJ, Thery JC, Blot E. Ouvrier MJ, et al. J Clin Oncol. 2006 Dec 10;24(35):5614; author reply 5614-5. doi: 10.1200/JCO.2006.09.0571. J Clin Oncol. 2006. PMID: 17158551 No abstract available.
• [Guidelines for prevention of febrile neutropenia].

  Barroso S, Damasceno M, Dinis J, Gervásio H, da Luz R, Passos-Coelho JL, Sá A, Costa L, Rodrigues H, Andrade S, Macedo A, Moital I. Barroso S, et al. Acta Med Port. 2008 Jan-Feb;21(1):7-19. Epub 2008 Apr 18. Acta Med Port. 2008. PMID: 18489831 Review. Portuguese.